Dr. Douglas Evans | Surgery | Best Researcher Award

Posted on by sciencefather

Dr. Douglas Evans | Surgery | Best Researcher Award

Dr. Douglas Evans, Medical College of Wisconsin, United States

Dr. Douglas B. Evans is a distinguished leader in surgical oncology and currently serves as Chair of the Department of Surgery at the Medical College of Wisconsin. His medical expertise focuses on pancreatic cancer and complex surgical oncology, where he has made significant contributions through his leadership and research. He is highly respected for his extensive work at prestigious institutions, including the University of Texas MD Anderson Cancer Center, where he previously held a tenured professorship. Dr. Evans’ commitment to advancing cancer research and improving patient care has earned him recognition nationally and internationally. He has served on multiple national advisory boards and contributed to various scientific committees. Dr. Evans’ work continues to impact the fields of surgery and oncology, enhancing the understanding and treatment of pancreatic cancer.

Professional Profile

scopus

google scholar

Summary of Suitability for the Research for Best Researcher Award

Dr. Douglas B. Evans, with his extensive background in surgical oncology and a distinguished career, is highly suited for the Research for Best Researcher Award. His leadership as Chair of the Department of Surgery at the Medical College of Wisconsin since 2009 demonstrates his commitment to advancing surgical practices and medical education. His impressive list of academic and clinical roles, including his tenure as a professor at the University of Texas M. D. Anderson Cancer Center, highlights his sustained contributions to the field of cancer research, particularly in pancreatic and thyroid cancers.

🎓 Education 

Dr. Douglas B. Evans received his foundational education at Oliver Ames High School in North Easton, Massachusetts. He then attended Bates College in Lewiston, Maine, where he earned his Bachelor of Science degree. His medical journey continued at Boston University School of Medicine, where he obtained his M.D. Following this, Dr. Evans pursued postgraduate training in surgery at Dartmouth-Hitchcock Medical Center, where he completed both his internship and residency in general surgery. His specialization in surgical oncology was honed during his fellowship at the University of Texas MD Anderson Cancer Center. This extensive academic background provided him with the expertise required to become a leading figure in the surgical treatment of pancreatic and gastrointestinal cancers. His licensures include multiple states such as Texas and Wisconsin, and he is board-certified by the American Board of Surgery, with recertifications reflecting his continued commitment to excellence in surgical practice.

💼  Experience 

Dr. Douglas B. Evans has an extensive career in surgical oncology, marked by significant leadership roles. He began as an Instructor in Surgery at Dartmouth Medical School and progressed to Teaching Associate at the University of Texas MD Anderson Cancer Center. At MD Anderson, Dr. Evans ascended from Assistant Professor to full Professor of Surgery, eventually securing the Hamill Foundation Distinguished Professorship in honor of Dr. Richard G. Martin, Sr. Since 2009, he has been the Chair of the Department of Surgery at the Medical College of Wisconsin, where he also holds the Ausman Family Foundation Chair. Dr. Evans’ career highlights include serving as Surgeon-in-Chief at Froedtert Hospital and contributing to numerous advisory boards and national committees. His experience and influence in academic surgery, particularly in pancreatic cancer research and treatment, have established him as a key figure in the surgical oncology field.

🏅 Awards and Honors 

Dr. Douglas B. Evans has received numerous awards and honors throughout his distinguished career in surgical oncology. Early recognition came with the Resident’s Publication Award in 1985, followed by the prestigious Thomas P. Almy Award in 1987. His dedication to teaching was acknowledged by multiple Outstanding Teacher Awards, notably in 1995 and 2003 at the University of Texas MD Anderson Cancer Center. In 1999, he was awarded the American College of Surgeons Traveling Fellowship. More recently, Dr. Evans was honored with the Andrew L. Warshaw Master Educator Award in 2014 from the Society for Surgery of the Alimentary Tract, as well as the Wisconsin Way Award in Medicine in 2018. In 2021, he was appointed to the Douglas B. Evans Chair for Surgical Research, a testament to his contributions to both clinical practice and academic surgery. In 2023, he received the Benjamin E. Mays Medal from Bates College, their highest alumni honor.

🌍 Research Focus

Dr. Douglas B. Evans’ research primarily focuses on the surgical treatment of pancreatic cancer and complex gastrointestinal cancers. His work has significantly advanced the understanding of pancreatic tumor biology and the development of surgical techniques to improve patient outcomes. He is particularly interested in translational research that bridges basic science discoveries and clinical applications. Dr. Evans has contributed to groundbreaking studies on the molecular mechanisms driving pancreatic cancer, enhancing the accuracy of surgical interventions and postoperative care. His research has been pivotal in the development of multi-disciplinary treatment approaches that combine surgery with chemotherapy and radiation therapy for pancreatic and other gastrointestinal cancers. As a renowned leader in his field, Dr. Evans has published extensively in high-impact medical journals, and his research efforts continue to shape the landscape of surgical oncology and improve the prognosis for cancer patients worldwide.

📖 Publication Top Notes

  • One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
    • Citation: 5547
  • Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement
    • Citation: 1921
  • Medullary thyroid cancer: management guidelines of the American Thyroid Association
    • Citation: 1712
  • Cancer-associated stromal fibroblasts promote pancreatic tumor progression
    • Citation: 1310
  • Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy
    • Citation: 1012

Dr. Cedric Anthierens | Marine Robotics | Business Innovation Award

Posted on by sciencefather

Dr. Cedric Anthierens | Marine Robotics | Business Innovation Award

Dr. Cedric Anthierens, COSMER Lab, University of Toulon, France

Cédric Anthierens is an Associate Professor at the University of Toulon, where he heads the mechatronics and robotics department at the Seatech Engineering School. A graduate of INSA of Lyon in 1996, Cédric earned his PhD in microrobotics in 1999. His academic career spans two decades, during which he has focused on research in marine and submarine robotics. At the COSMER Lab, his work includes developing underwater robots, umbilical management systems, and cooperation between autonomous surface and underwater vehicles. Beyond academia, Cédric collaborates with industry leaders like AlcenAlseamar, managing fleets of autonomous gliders to further enhance maritime exploration technologies.

Professional Profile

Orcid

Summary of Suitability for the Research for Business Innovation Award 

Cédric Anthierens demonstrates strong qualifications for the Research for Business Innovation Award, with a unique blend of academic research and real-world business innovation. As an Associate Professor at the University of Toulon’s COSMER Lab, his work focuses on marine and submarine robotics, with a specific emphasis on autonomous surface and underwater vehicles. This field of research directly contributes to cutting-edge advancements in marine technology, offering practical applications in industries like defense, ocean exploration, and environmental monitoring.

 🎓  Education 

Cédric Anthierens holds a degree in Engineering from INSA Lyon, a prestigious French engineering school, which he completed in 1996. He pursued further studies in robotics, earning a PhD in microrobotics in 1999. His doctoral research focused on the intricacies of micromechanical systems, laying the foundation for his career in marine robotics. He further honed his expertise through various advanced research programs, specializing in underwater vehicle navigation and autonomous robotics. His academic background, a blend of theoretical and practical experience, has been instrumental in shaping the curriculum at the Seatech Engineering School, where he now leads the mechatronics and robotics department.

💼   Experience 

Cédric Anthierens has extensive experience in the field of robotics, particularly in marine and underwater systems. Since joining the University of Toulon in 2014, he has served as the head of the mechatronics and robotics department at Seatech Engineering School. His research focuses on creating autonomous systems for both surface and underwater vehicles, and he has collaborated with leading organizations such as AlcenAlseamar and Sherpa Engineering. Through projects like fleet management of autonomous underwater gliders and advanced algorithms for robotic path planning, he has contributed significantly to the field of marine robotics. His academic and industrial experience positions him as a key figure in advancing underwater robotic technologies.

🏅  Awards and Honors 

Cédric Anthierens has received numerous accolades for his contributions to marine and robotics research. His work on developing underwater robotic systems has garnered recognition from both academic and industrial organizations. He has been honored for his innovations in autonomous vehicle navigation and path planning, including awards for excellence in innovation. His leadership in managing industry collaborations, particularly with AlcenAlseamar, has also been acknowledged, as he played a pivotal role in advancing the capabilities of autonomous underwater gliders. As an academic leader, Cédric has received institutional awards for his contributions to the Seatech Engineering School, where he has successfully led the mechatronics and robotics department.

🌍  Research Focus 

Cédric Anthierens’ research primarily revolves around the development of autonomous marine and submarine robotic systems. His focus is on improving the intelligence and effectiveness of glider fleets, advancing algorithms for underwater vehicle navigation, and optimizing robotic path planning. He has worked extensively on cooperative systems between autonomous surface vehicles (USVs) and underwater vehicles (ROVs), particularly addressing umbilical management between these systems. At the COSMER Lab, his research has led to the creation of simulation tools that enhance the planning and execution of underwater missions, enabling robots to perform tasks more efficiently. His collaboration with industrial partners has also contributed to practical advancements in maritime robotics.

📖 Sustainable SolutionsPublications Top Notes

  •  Automated Deployment of an Underwater Tether Equipped with a Compliant Buoy–Ballast System for Remotely Operated Vehicle Intervention
  •  A New Flex-Sensor-Based Umbilical-Length Management System for Underwater Robots
  •  A Simulator of Underwater Glider Missions for Path Planning
  •  Towards Active Self-Management of Umbilical Linking ROV and USV for Safer Submarine Missions
  •  Sensory Navigation Guide for Visually Impaired Sea Kayakers

Assist. Prof. Dr. Ebtesam Yousef | Ostracoda | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Ebtesam Yousef | Ostracoda | Best Researcher Award

Assist. Prof. Dr. Ebtesam Yousef, Assistant Professor of Faculty of Science, Egypt

Ebtesam Ahmed Yousef Abd elhaleem is an Assistant Professor at the Zoology Department, Faculty of Science, Sohag University, Egypt. Born on December 26, 1974, in Sohag, Egypt, she has made significant contributions to the field of invertebrate zoology, particularly marine ostracods. With an extensive background in taxonomy and biological studies, she has published numerous research papers on the biodiversity and ecology of marine species in the Red Sea. Fluent in Arabic, English, and German, she brings a diverse set of skills, including expertise in Microsoft Office, Photoshop, and statistical software like SPSS. She is committed to advancing zoological research and educating future generations of scientists.

Professional Profile

Scopus

Summary of Suitability for the Research for Best Researcher Award

Dr. Ebtesam Ahmed Yousef Abd elhaleem is a strong candidate for the ‘Research for Best Researcher Award.’ Her extensive research on ostracods, contributions to marine biodiversity, and commitment to academic excellence through teaching and journal refereeing make her highly suitable for the award. Her work aligns with the objectives of the award, recognizing researchers who contribute significantly to their field while promoting academic growth and innovation.

🎓 Education

Ebtesam completed her undergraduate degree in Zoology at Sohag Faculty of Science, Assiut University in 1996. She then progressed to obtain her Master’s degree in 2003, focusing on taxonomic and morphological studies of marine ostracods from the Red Sea. Her Ph.D., awarded by Sohag University in 2008, expanded on these studies, delving deeper into the biological traits of ostracod species from the Red Sea. Her research contributed significantly to the understanding of marine biodiversity and invertebrate taxonomy. Ebtesam’s expertise in zoology, particularly in studying ostracods, has positioned her as a key academic in this field.

💼 Experience 

Ebtesam has a broad academic career, starting as a demonstrator in 1997 before moving into research and teaching roles. She has been an Assistant Professor at Sohag University since 2018, where she teaches undergraduate and postgraduate courses, including invertebrate taxonomy, vertebrate anatomy, and general physiology. Her research focuses on marine crustaceans, specifically ostracods, contributing new knowledge on species diversity in Egypt’s Red Sea. Additionally, Ebtesam is a peer reviewer for several scientific journals, such as Invertebrate Reproduction & Development Journal and BMC Zoology Journal. Her teaching and research excellence continue to inspire her students and peers.

🏅Awards and Honors 

Ebtesam has received numerous accolades for her academic contributions. Among her most notable achievements is her promotion to Assistant Professor in 2018, reflecting her strong academic standing and dedication to zoological research. She has also been recognized for her scientific papers on the taxonomy and biology of marine ostracods, with several of her publications being featured in high-impact journals. Ebtesam’s research has not only garnered respect within academic circles but has also contributed to the greater understanding of marine biodiversity in the Red Sea region.

🌍 Research Focus 

Ebtesam’s research primarily revolves around marine biodiversity, focusing on the taxonomy and ecology of ostracods, a group of small crustaceans found in marine environments. Her studies on the Red Sea ostracods have provided new insights into species diversity, ecological roles, and adaptation to marine habitats. She is particularly interested in how environmental factors affect ostracod populations and their ecological significance. Through her research, she aims to contribute to global conservation efforts by highlighting the importance of marine ecosystems in Egypt and beyond.

📖 Publication Top Notes

Effect of Environmental Variables on Zooplankton in Various Habitats of the Nile River
Citation: 1
Therapeutic efficacy of geranium-thymol combination against murine eimeriosis with reference to its apoptotic activity
Morphology and molecular identification of Heterocypris incongruens female from AlUla, Kingdom of Saudi Arabia
Morphological re-Description and molecular characterization of heterocypris salina (Brady, 1868), A new recorded ostracod species in Egypt
Citation: 5
The ontogeny of appendages and carapace of Neonesidea schulzi (Ostracoda: Bairdiidae) from the Red Sea coast, Egypt
Citation: 1

Mr. Malu Daniel | Biotechnology | Research Excellence Award

Posted on by sciencefather

Mr. Malu Daniel | Biotechnology | Research Excellence Award

Mr. Malu Daniel, University of Calabar, Calabar, Nigeria, Nigeria

MR. DANIEL GATIE MALU is a dynamic researcher with a B.Sc. in Genetics and Biotechnology from the University of Calabar, Nigeria. His expertise lies in drug design, discovery, and molecular docking, where he utilizes computational techniques such as density functional theory (DFT) to address complex scientific challenges. His passion for drug delivery systems, particularly for genetic disorders like Cystic Fibrosis and cancers, fuels his ongoing research. Throughout his academic journey, Daniel has developed strong problem-solving skills, a collaborative mindset, and a commitment to scientific integrity. He is currently involved in a research program at the University of Calabar, where he is utilizing advanced computational tools to contribute to biosensor development, biomarkers, and drug modeling. He aims to further his knowledge through a Master’s degree, focusing on theoretical and computational modeling, with a drive to innovate in pharmaceutical and chemical research.

Professional Profile

Orcid

Summary of Suitability for the Award

MR. DANIEL GATIE MALU’s academic achievements, research experience, and dedication to utilizing advanced computational methods for drug design and bio-simulation, he is a strong candidate for the ‘Research for Excellence Award.’ His contributions to multidisciplinary research and his commitment to addressing critical global health issues through innovative scientific solutions make him well-suited for this recognition. His work has the potential for significant scientific impact, aligning well with the award’s criteria for research excellence.

🎓Education 

Daniel Gatie Malu holds a B.Sc. in Genetics and Biotechnology from the University of Calabar, Nigeria, graduating in 2024. His undergraduate thesis, titled “Molecular Modeling of the Spectroscopic Structural and Bioactive Potential of Azadirachta indica against Plasmodium falciparum”, highlights his deep interest in molecular modeling and drug discovery. Daniel explored phytochemical analysis, including GCMS, HPLC, FT-IR, and UV-Vis analysis, to investigate the bioactive potential of plant compounds. His academic focus was on theoretical and experimental approaches to understanding drug interactions with biological systems, utilizing modern computational techniques. The thesis also involved evaluating stability, reactivity, and binding potential of compounds, laying a strong foundation for his future research endeavors. This academic background equipped him with a solid understanding of computational biology, molecular chemistry, and bioinformatics, and he seeks to apply this knowledge to cutting-edge research in drug design and theoretical modeling.

 💼 Experience 

MR. DANIEL GATIE MALU has a diverse research background, starting with his industrial training at Biggmade Scientific Research Academy in 2023. There, he conducted serological tests and explored bioinformatics, focusing on drug-protein interactions. He also performed DNA extraction and plant tissue culture. Since November 2023, he has been part of the Computational and Bio-Simulation Research Group at the University of Calabar, where he is immersed in full-time research. Daniel leverages advanced computational tools such as Gaussian 16, AutoDock Vina, and PyMOL to conduct molecular docking and density functional theory (DFT) studies. His interdisciplinary research spans biosensors, biomarkers, and drug delivery systems. He has also contributed to academic publications and collaborated with peers across various scientific disciplines. Daniel’s mentorship of students and his role in academic projects demonstrate his commitment to fostering intellectual growth within his community.

🏅Awards and Honors 

Daniel Gatie Malu has earned recognition for his academic excellence and contributions to scientific research. In 2024, he became a student member of the Royal Society of Chemistry, which highlights his growing prominence in the field. His work has been instrumental in several key publications and research projects, earning him respect among his peers and mentors. His interdisciplinary research, particularly in molecular docking, density functional theory (DFT), and computational modeling, has been acknowledged within the scientific community. Throughout his academic career, Daniel has demonstrated a strong commitment to advancing knowledge in the fields of biotechnology and drug design, earning him multiple awards for his research contributions at the university level. His passion for innovative solutions in drug delivery and biosensor development has also positioned him as an emerging leader in computational biology and pharmaceutical research.

🌍 Research Focus 

Daniel Gatie Malu’s research focus lies at the intersection of computational chemistry, molecular biology, and drug discovery. He employs density functional theory (DFT) and molecular docking techniques to investigate drug-target interactions, specifically for diseases like Cystic Fibrosis, Huntington’s Disease, and various cancers (BRCA1/BRCA2). Daniel is particularly interested in the design of advanced drug delivery systems such as nanoparticles and liposomes for controlled release and targeted therapies. He also explores high-throughput screening (HTS) to identify active compounds from chemical libraries, focusing on improving the pharmacokinetic and safety profiles of potential drug candidates. Additionally, Daniel investigates the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of these compounds. His interdisciplinary research extends to biosensors and biomarkers, leveraging computational methods for innovative applications in both pharmaceuticals and environmental sciences.

📖 Publications Top Notes

How does the long G·G* Watson-Crick DNA base mispair comprising keto and enol tautomers of the guanine tautomerise? The results of a QM/QTAIM investigation.

 

kelig mahe | fisheries research | Research Excellence Award

Posted on by sciencefather

Dr kelig mahe | fisheries research | Research Excellence Award

Dr.kelig mahe, Ifremer, France

Dr. Kélig MAHE is a leading researcher at IFREMER, specializing in marine science, particularly in the fields of sclerochronology and fisheries. Since 2021, he has been the head of the Halieutiques Manche-Mer du Nord Unit, overseeing numerous national and European projects related to fish age estimation and stock management. Dr. MAHE’s expertise spans biological data coordination, fish age determination workshops, and the development of TNPC software. He has co-supervised 11 PhD students and 12 master’s students, contributing significantly to scientific innovation, as demonstrated by his 2010 award for scientific and technological innovation at IFREMER. His contributions extend internationally, with leadership in numerous European research collaborations.

Professinal Profile

  • orcid

    Education 

    Dr. Kélig MAHE’s academic journey is rooted in marine and environmental sciences. He earned his PhD in Marine Biology from Université du Littoral Côte d’Opale (ULCO) in 2019, focusing on fisheries and environmental ecosystems. Prior to this, he completed his Diplôme d’Etudes Approfondies (DEA) in Coastal and Littoral Ecosystem Dynamics from ULCO in 2002. Dr. MAHE’s foundational knowledge in marine resource management was shaped during his engineering studies at the prestigious Ecole Nationale Supérieure d’Agronomie de Rennes (ENSAR), where he graduated with a specialization in Halieutics in 2003. His multidisciplinary education also includes a Maîtrise des Sciences et Techniques in Environmental Sciences from the University of Rouen, completed in 2001, providing him with a well-rounded scientific background in both marine biology and environmental management.

    Experience 

    Dr. MAHE Kélig has an extensive research career at IFREMER, where he has been actively engaged since 2007. His role evolved from a research cadre to leading the Halieutiques Manche-Mer du Nord Unit in 2021. His vast experience includes coordinating national biological data, managing research programs on fish age estimation, and providing expert advice on stock management. His involvement in European research projects is extensive, including leadership positions in projects like Med-Units, Sumaris, and Microtolithe. Dr. MAHE has also represented IFREMER in international workshops and played a pivotal role in advancing sclerochronology, both through research and the development of TNPC software. His management experience includes overseeing teams and mentoring students, making significant contributions to both scientific research and talent development.

    Awards and Honors 

    Dr. MAHE Kélig’s distinguished contributions to marine science have earned him notable recognition. In 2010, he was awarded the IFREMER Trophée de l’innovation for his pioneering work in scientific, technical, and technological fields. His leadership and contributions have made a global impact, notably in European research collaborations, where he co-chaired 13 international workshops and participated in 4 European working groups. His expertise in sclerochronology has positioned him as an expert for IFREMER in international fora. Dr. MAHE’s influence extends to organizing international symposia, such as the 6th International Symposium on Biological Shape Analysis in 2019. His collaborative spirit and innovative work have consistently advanced marine research, particularly in fisheries biology, earning him respect and recognition within the global scientific community.

    Research Focus

    Dr. MAHE Kélig’s research centers on sclerochronology, the study of calcified structures in fish, to improve age determination methods and enhance fisheries management. His work plays a critical role in understanding fish population dynamics and the impacts of environmental changes, such as temperature fluctuations and CO2 levels, on marine species. Dr. MAHE has been at the forefront of integrating modern technologies in fisheries research, particularly through his contributions to the TNPC software for processing calcified structures. His research also extends to interdisciplinary collaborations, where he has led and participated in numerous European projects, focusing on sustainable fishery practices, species population structures, and biogeographical studies. His commitment to research excellence is evidenced by his active role in advancing knowledge in otolith morphogenesis, age determination, and stock management, all of which are pivotal for sustainable marine resource management.

     Publications Top Notes

    1. 🐟 Asymmetry of Sagittal Otolith Shape in Mediterranean Red Mullet: Comparative Analysis of 2D and 3D Otolith Shape Data (2023).
    2. 🌊 Effect of Temperature and CO2 on Morphogenesis of Sagittal Otoliths in Atlantic Herring (2023).
    3. 📊 Spatial Structuring of Demersal Fish Around Réunion Island Based on Otolith Shape (2023).
    4. 🧬 New Scale Analyses Reveal Centenarian African Coelacanths (2021).
    5. 🐠 Complementarity and Discriminatory Power of Genotype and Otolith Shape in Eastern English Channel Sole (2020).

Arnulf Stenzl | Health Professions | Academic Excellence Award

Posted on by sciencefather

Prof Dr Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl, Universität Tübingen, Tübingen Deutschland ,Germany

Prof. Dr. Arnulf Stenzl is an Austrian-born urologist and global leader in urological oncology. He received his medical degree from Karl-Franzens University in Graz, Austria, in 1980 and subsequently trained in surgery and urology across Austria, Switzerland, and the United States. Since 2002, he has headed the Department of Urology at Eberhard-Karls University in Tübingen, Germany, where he oversees critical research on urological cancers. Prof. Stenzl’s contributions extend internationally, with membership in numerous editorial boards and global collaborations. He has played a pivotal role in shaping European urological policies as Secretary General of the European Association of Urology. His work has led to several groundbreaking patents in the field, furthering innovations in patient care.

Professional Profile

Education 

Prof. Dr. Arnulf Stenzl embarked on his academic journey in 1973 when he enrolled at Karl-Franzens University in Graz, Austria, where he earned his Doctor medicinae universalis (M.D.) in February 1980. His initial training spanned internal medicine, nephrology, and pathology at Landeskrankenhaus Klagenfurt and Karl-Franzens University. From 1984 to 1987, he undertook specialized training in urology, first at Karl-Franzens University, then further expanding his knowledge as a fellow in general urology and urologic oncology at the University of California, Los Angeles (UCLA). His education, which encompassed diverse fields such as trauma, vascular, and plastic surgery, provided him with a holistic understanding of medicine and surgery. His dedication to learning has been reflected in his ongoing research and innovative contributions to urology.

Experience 

Prof. Dr. Arnulf Stenzl has had a distinguished career spanning over three decades. After serving as an assistant professor at the University of Bern in Switzerland, he moved to the University of Innsbruck, Austria, where he eventually became vice-chairman of the Department of Urology. Since 2002, he has led the Department of Urology at Eberhard-Karls University Tübingen, Germany, overseeing the clinical, academic, and research arms of the institution. Prof. Stenzl has driven numerous groundbreaking research projects, collaborating with both academic and industrial partners. As Secretary General of the European Association of Urology, he has led European urological research and development initiatives. His expertise extends to cancer research, with numerous contributions to advancing treatment modalities for bladder and prostate cancer.

Awards and Honors 

Prof. Dr. Arnulf Stenzl’s career is marked by numerous prestigious awards and honors. He is an honorary member of several international urological societies, including the Bristol Urological Institute and the Canadian Urological Association. His service as President of the German Urological Association (2020-2021) highlights his leadership within the field. Additionally, his involvement as Chairman of the Scientific Congress Office for the European Association of Urology and his role on the Board of Directors of the European CanCer Organisation demonstrate his commitment to global urological advancement. Prof. Stenzl’s contributions to scientific literature have earned him multiple editorial board memberships. His innovative spirit is further evidenced by several patents, including implantable devices to treat urinary incontinence and risk prediction models for renal cell carcinoma.

Research Focus 

Prof. Dr. Arnulf Stenzl’s research is at the forefront of urological oncology, focusing on advanced treatment modalities for bladder and prostate cancers. His work delves into personalized cancer therapies, optimizing clinical outcomes through precision medicine approaches. A significant aspect of his research revolves around biomarker discovery and risk stratification, which aim to enhance early diagnosis and targeted treatment. He has contributed to pioneering studies in immunotherapy, including innovative techniques for bladder cancer surgery and the integration of novel hormonal therapies in prostate cancer treatment. Prof. Stenzl is also involved in collaborative research projects with industry, furthering the development of next-generation urological treatments. His innovative contributions have resulted in several patents, solidifying his standing as a leader in urological research and technology.

Publications top notes

  • Treatment Intensification With Novel Hormonal Therapy in Prostate Cancer 📚🧪
  • Sacituzumab Govitecan Efficacy in Urothelial Cancer 🧬🔬
  • Co-occurring BRCA2/SPOP Mutations and PARP Inhibitor Sensitivity 🧬⚕️
  • Epacadostat Plus Pembrolizumab for Urothelial Carcinoma 💉🧪
  • Impact of Teratoma on Survival in Germ Cell Cancer 🧫🩺
  • Sacituzumab Govitecan & Pembrolizumab in Urothelial Cancer 💊🧪
  • TROPHY-U-01 Study on Sacituzumab Govitecan in Metastatic Urothelial Cancer 🧬🔬
  • Efficacy of Darolutamide in Black Patients With Prostate Cancer ⚕️🩺
  • Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer 🧬💉